MAIT cells numbers and frequencies in patients with acute myeloid leukemia at diagnosis: association with cytogenetic profile and gene mutations.

Comont, Thibault; Nicolau-Travers, Marie-Laure; Bertoli, Sarah; Recher, Christian; Vergez, Francois; Treiner, Emmanuel

Comont, Thibault; Nicolau-Travers, Marie-Laure; Bertoli, Sarah; Recher, Christian; Vergez, Francois; Treiner, Emmanuel.

Afiliación

Comont T; Department of Internal Medicine, IUCT-Oncopole, CHU Toulouse, Toulouse, France.
Nicolau-Travers ML; Laboratory of Hematology, IUCT-Oncopole, CHU Toulouse, Toulouse, France.
Bertoli S; Cancer Research Center of Toulouse, Unité Mixte de Recherche (UMR) 1037 INSERM, ERL5294 Centre National de La Recherche Scientifique, Toulouse, France.
Recher C; Laboratory of Hematology, IUCT-Oncopole, CHU Toulouse, Toulouse, France.
Vergez F; Cancer Research Center of Toulouse, Unité Mixte de Recherche (UMR) 1037 INSERM, ERL5294 Centre National de La Recherche Scientifique, Toulouse, France.
Treiner E; Department of Clinical Hematology, IUCT-Oncopole, CHU Toulouse, Toulouse, France.

Cancer Immunol Immunother ; 71(4): 875-887, 2022 Apr.

Article en En | MEDLINE | ID: mdl-34477901

Asunto(s)

Leucemia Mieloide Aguda; Células T Invariantes Asociadas a Mucosa; Análisis Citogenético; Humanos; Leucemia Mieloide Aguda/diagnóstico; Leucemia Mieloide Aguda/genética; Mutación; Estudios Prospectivos

Palabras clave

AML; Immune surveillance; Immunotherapy; MAIT; MR1

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Células T Invariantes Asociadas a Mucosa Tipo de estudio: Diagnostic_studies / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Cancer Immunol Immunother Asunto de la revista: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Año: 2022 Tipo del documento: Article País de afiliación: Francia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google